// App-Quantinova.ai

982 : Evaluating Outcomes of Adult Patients with Acute Lymphoblastic Leukemia Treated on the GMALL Protocol

Researchers

Presenter

  • Danielle Fredman

Principal Investigators

  • Yulia Volchek

  • Gabriel Heering

  • Keren Shichrur

  • Ronit Yerushalmi

  • Noga Shem-Tov

  • Elena Ribakovsky

  • Avichai Shimoni

  • Abraham Avigdor

  • Arnon Nagler

  • Jonathan Canaani

Medical Centers

  • Chaim Sheba Medical Center, Tel Hashomer, Israel

  • Division of Hematology and Bone Marrow Transplantation, The Chaim Sheba Medical Center, Tel-Hashomer, Ramat-Gan , Israel

  • Molecular Oncology, Felsenstein Medical Research Center, Petah-Tikva, Israel,

  • Division of Hematology and Bone Marrow Transplantation, The Chaim Sheba Medical Center, Tel-Hashomer, Ramat-Gan , Israel

  • Division of Hematology, Chaim Sheba Medical Center, Ramat Gan, Israel

  • Institute of Oncology, Sheba Medical Center, Ramat Gan, Israel

  • Director Division of Hematology Chaim Sheba Medical Center, Tel Hashomer, Israel

  • Hematology,Sheba Medical Center,Givatayim,Israel

Locations

  • Israel

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved